Fractyl Health’s (NASDAQ:GUTS – Get Free Report) lock-up period will expire on Wednesday, July 31st. Fractyl Health had issued 7,333,333 shares in its public offering on February 2nd. The total size of the offering was $109,999,995 based on an initial share price of $15.00. After the expiration of the company’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
Fractyl Health Price Performance
Shares of Fractyl Health stock opened at $4.09 on Tuesday. The company has a 50-day moving average price of $5.32. Fractyl Health has a fifty-two week low of $3.77 and a fifty-two week high of $14.50. The company has a debt-to-equity ratio of 0.34, a current ratio of 9.38 and a quick ratio of 9.37.
Fractyl Health (NASDAQ:GUTS – Get Free Report) last posted its earnings results on Monday, May 13th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.45). The firm had revenue of $0.03 million during the quarter. On average, equities analysts forecast that Fractyl Health will post -2.03 EPS for the current fiscal year.
Hedge Funds Weigh In On Fractyl Health
About Fractyl Health
Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
See Also
- Five stocks we like better than Fractyl Health
- Stock Sentiment Analysis: How it Works
- Survey: Top 175 Fittest Retirement Locations in America
- What Investors Need to Know to Beat the Market
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- How to Invest in Biotech Stocks
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Fractyl Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fractyl Health and related companies with MarketBeat.com's FREE daily email newsletter.